Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter June 26, 2006

Cellular distribution of human tissue kallikreins: immunohistochemical localization

  • Constantina D. Petraki , Panagiotis A. Papanastasiou , Vassiliki N. Karavana and Eleftherios P. Diamandis
From the journal Biological Chemistry

Abstract

We have studied the immunohistochemical expression (IE) of eight non-tissue-specific human kallikreins (hKs) (hK5, 6, 7, 10, 11, 12, 13, and 14) in different normal tissues. The IE was always cytoplasmic, showing a characteristic pattern in some tissues. Comparison of the IE of all hKs studied in the different tissues revealed no major differences, suggesting that they share a common mode of regulation. Furthermore, hKs were immunohistochemically revealed in a variety of tissues, indicating that no protein is tissue-specific (except for hK2 and hK3, which have tissue-restricted expression). In general, our results correspond well with data from RT-PCR and ELISA assays. Glandular epithelia constitute the main kallikrein IE sites, and the staining in their secretions confirms that these proteases are secreted. A variety of other tissues express the proteins as well. We have also immunohistochemically evaluated all the above hKs in several malignant tissues. Tumors arising from tissues expressing kallikreins tested positive. Corresponding to the IE in normal glandular tissues, most hKs were expressed in adenocarcinomas. The prognostic value of several hKs was studied in series of prostate, renal cell, colon and urothelial carcinomas.

:

Corresponding author

References

Abrahamsson, P.A., Lilja, H., Falkmer, S., and Wadstrom, L.B. (1988). Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands. Prostate12, 39–46.10.1002/pros.2990120106Search in Google Scholar

Bhoola, K.D., Figueroa, C.D., and Worthy, K. (1992). Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev.44, 1–80.Search in Google Scholar

Bhoola, K., Ramsaroop, R., Plendl, J., Cassim, B., Dlamini, Z., and Naicker, S. (2001). Kallikrein and kinin receptor expression in inflammation and cancer. Biol. Chem.382, 77–89.10.1515/BC.2001.013Search in Google Scholar

Black, M.H., and Diamandis, E.P. (2000). The diagnostic and prognostic utility of prostate specific antigen for diseases of the breast. Breast Cancer Res. Treat.59, 1–4.10.1023/A:1006380306781Search in Google Scholar

Black, M.H., Magklara, A., Obiezu, C., Levesque, M.A., Sutherland, D.J., Tindall, D.J., Young, C.Y., Sauter, E.R., and Diamandis, E.P. (2000). Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumors and in normal breast secretions. Br. J. Cancer82, 361–367.10.1054/bjoc.1999.0927Search in Google Scholar

Borgono, C.A. and Diamandis, E.P. (2004). The emerging roles of human tissue kallikreins in cancer. Nat. Rev. Cancer4, 876–890.10.1038/nrc1474Search in Google Scholar

Cane, S., Bignotti, E., Bignotti, E., Bellone, S., Palmieri, M., De las Casas, L., Roman, J.J., Pecorelli, S., Cannon, M.J., O'Brien, T., and Santin, A.D. (2004). The novel serine protease tumor-associated differentially expressed gene-14 (KLK8/neuropsin/ovasin) is highly overexpressed in cervical cancer. Am. J. Obstet. Gynecol.190, 60–66.10.1016/j.ajog.2003.07.020Search in Google Scholar

Chang, A., Yousef, G.M., Jung, K., Rajpert-de Meyts, E., and Diamandis, E.P. (2001). Identification and molecular characterization of five novel kallikrein gene (KLK13; KLK14) splice variants: differential expression in the human testis and testicular cancer. Anticancer Res.21, 3147–3152.Search in Google Scholar

Chang, A., Yousef, G.M., Scorilas, A., Grass, L., Sismondi, P., Ponzone, R., and Diamandis, E.P. (2002). Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancer. Br. J. Cancer86, 1457–1464.10.1038/sj.bjc.6600283Search in Google Scholar

Chao, J., Sostek, M., Shimamoto, K., Bank, H.L., Bigelow, J., and Margolius, H.S. (1980). Kallikrein content of rat pancreatic acinar cells or islets by direct radioimmunoassay. Hoppe-Seyler's Z. Physiol. Chem.361, 1805–1810.10.1515/bchm2.1980.361.2.1805Search in Google Scholar

Chu, T.M. (1997). Prostate-specific antigen and early detection of prostate cancer. Tumor Biol.18, 123–134.10.1159/000218023Search in Google Scholar

Clements, J.A. (1998). Current perspectives on the molecular biology of the renal tissue kallikrein gene and the related tissue kallikrein gene family. Biol. Res.31, 151–159.Search in Google Scholar

Clements, J. and Mukhtar, A. (1994). Glandular kallikreins and prostate-specific antigen are expressed in the human endometrium. J. Clin. Endocrinol. Metab.78, 1536–1539.Search in Google Scholar

Clements, J. and Mukhtar, A. (1997). Tissue kallikrein and the bradyinin B2 receptor are expressed in endometrial and prostate cancers. Immunopharmacology36, 217–220.10.1016/S0162-3109(97)00024-6Search in Google Scholar

Clements, J., Mukhtar, A., Ehrlich, A., and Yap, B. (1994). Glandular kallikrein gene expression in the human uterus. Braz. J. Med. Biol. Res.27, 1853–1863.Search in Google Scholar

Clements, J.A., Mukhtar, A., Verity, K., Pullar, M., McNeill, P., Cummins, J., and Fuller, P.J. (1996). Kallikrein gene expression in human pituitary tissues. Clin. Endocrinol.44, 223–231.10.1046/j.1365-2265.1996.661481.xSearch in Google Scholar

Clements, J.A., Willemsen, N.M., Myers, S.A., and Dong, Y. (2004). The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers. Crit. Rev. Clin. Lab. Sci.41, 265–312.10.1080/10408360490471931Search in Google Scholar

Cumming, A.D., Walsh, T., Wojtacha, D., Fleming, S., Thomson, D., and Jenkins, D.A. (1994). Expression of tissue kallikrein in human kidney. Clin. Sci. (Lond.)87, 5–11.10.1042/cs0870005Search in Google Scholar

Darson, M.F., Pacelli, A., Roche, P., Rittenhouse, H.G., Wolfert, R.L., Young, C.Y., Klee, G.G., Tindall, D.J., and Bostwick, D.G. (1997). Human glandular kallikrein 2 (hK2) expression in prostate intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker. Urology49, 857–862.10.1016/S0090-4295(97)00108-8Search in Google Scholar

Darson, M.F., Pacelli, A., Roche, P., Rittenhouse, H.G., Wolfert, R.L., Saeid, M.S., Young, C.Y., Klee, G.G., Tindall, D.J., and Bostwick, D.G. (1999). Human glandular kallikrein 2 expression in prostate adenocarcinoma and lymph node metastases. Urology53, 939–944.10.1016/S0090-4295(98)00637-2Search in Google Scholar

Davidson, B., Xi, Z., Klokk, T.I., Trope, C.G., Dorum, A., Scheistroen, M., and Saatcioglu, F. (2005). Kallikrein 4 expression is up-regulated in epithelial ovarian carcinoma cells in effusions. Am. J. Clin. Pathol.123, 360–368.10.1309/PTBB5BPCKX8K9V69Search in Google Scholar

Dedio, J., Wiemer, G., Rutten, H., Dendorfer, A., Scholkens, B.A., Müller-Esterl, W., and Wohlfart, P. (2001). Tissue kallikrein KLK1 is expressed de novo in endothelial cells and mediates relaxation of human umbilical veins. Biol. Chem.382, 1483–1490.10.1515/BC.2001.182Search in Google Scholar

Diamandis, E.P., and Yousef, G.M. (2001). Human tissue kallikrein gene family: a rich source of novel disease biomarkers. Expert Rev. Mol. Diagn.1, 182–190.10.1586/14737159.1.2.182Search in Google Scholar

Diamandis, E.P., Yousef, G.M., Clements, J., Ashworth, L.K., Yoshida, S., Egelrud, T., Nelson, P.S., Shiosaka, S., Little, S., Lilja, H., et al. (2000a). New nomenclature for the human tissue kallikrein gene family. Clin. Chem.46, 1855–1858.10.1093/clinchem/46.11.1855Search in Google Scholar

Diamandis, E.P., Yousef, G.M., Luo, L.Y., Magklara, A., and Obiezu, C.V. (2000b). The new human kallikrein gene family: implications in carcinogenesis. Trends Endocrinol. Metab.11, 54–60.10.1016/S1043-2760(99)00225-8Search in Google Scholar

Diamandis, E.P., Yousef, G.M., Petraki, C., and Soosaipillai, A.R. (2000c). Human kallikrein 6 as a biomarker of Alzheimer's disease. Clin. Biochem.33, 663–667.10.1016/S0009-9120(00)00185-5Search in Google Scholar

Diamandis, E.P., Yousef, G.M., Soosaipillai, A.R., Grass, L., Porter, A., Little, S., and Sotiropoulou, G. (2000d). Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications. Clin. Biochem.33, 369–375.10.1016/S0009-9120(00)00145-4Search in Google Scholar

Diamandis, E.P., Okui, A., Mitsui, S., Luo, L.Y., Soosaipillai, A., Grass, L., Nakamura, T., Howarth, D.J., and Yamaguchi, N. (2002). Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma. Cancer Res.62, 295–300.Search in Google Scholar

Dietl, T., Kruck, J., and Fritz, H. (1978). Localization of kallikrein in porcine pancreas and submandibular gland as revealed by the indirect immunofluorescence technique. Hoppe-Seyler's Z. Physiol. Chem.359, 499–505.10.1515/bchm.1978.359.1.499Search in Google Scholar PubMed

Dong, Y., Kaushal, A., Bui, L., Chu, S., Fuller, P.J., Nicklin, J., Samaratunga, H., and Clements, J. (2001). Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas. Clin. Cancer Res.7, 2363–2371.Search in Google Scholar

Dong, Y., Kaushal, A., Brattsand, M., Nicklin, J., and Clements, J.A. (2003). Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers. Clin. Cancer Res.9, 1710–1720.Search in Google Scholar

Dong, Y., Bui, L.T., Odorico, D.M., Tan, O.L., Meyers, S.A., Samaratunga, H., Gardiner, R.A., and Clements, J.A. (2005). Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms. Endocr. Relat. Cancer12, 875–889.10.1677/erc.1.01062Search in Google Scholar PubMed

Gallee, M.P., Visser-de Jong, E., van der Korput, J.A., van der Kwast, T.H., ten Kate, F.J., Schroeder, F.H., and Trapman, J. (1990). Variation of prostate-specific antigen expression in different tumour growth patterns present in prostatectomy specimens. Urol. Res.18, 181–187.10.1007/BF00295844Search in Google Scholar PubMed

Hoffman, B.R., Katsaros, D., Scorilas, A., Diamandis, P., Fracchioli, S., Rigault de la Longrais, I.A., Colgan, T., Puopolo, M., Giardina, G., Massobrio, M., and Diamandis, E.P. (2002). Immunofluorometric quantitation and histochemical localization of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker. Br. J. Cancer87, 763–771.10.1038/sj.bjc.6600533Search in Google Scholar PubMed PubMed Central

Jaffa, A.A., Chai, K.X., Chao, J., Chao, L., and Mayfield, R.K. (1992). Effects of diabetes and insulin on expression of kallikrein and rennin genes in the kidney. Kidney Int.41, 789–795.10.1038/ki.1992.122Search in Google Scholar PubMed

Jones, T.H., Figueroa, C.D., Smith, C., Cullen, D.R., and Bhoola, K.D. (1990). Characterization of a tissue kallikrein in human prolactin-secreting adenomas. J. Endocrinol.124, 327–331.10.1677/joe.0.1240327Search in Google Scholar PubMed

Junes, M.J., Neuschatz, A.C., Bornstein, L.E., Naber, S.P., Band, V., and Wazer, D.E. (2003). Loss of expression of the putative tumor suppressor NES1 gene in biopsy-proven ductal carcinoma in situ predicts for invasive carcinoma at definitive surgery. Int. J. Radiat. Oncol. Biol. Phys.56, 653–657.Search in Google Scholar

Kim, H., Scorilas, A., Katsaros, D., Yousef, G.M., Massobrio, M., Fracchioli, S., Piccinno, R., Gordini, G., and Diamandis, E.P. (2001). Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer. Br. J. Cancer84, 643–650.10.1054/bjoc.2000.1649Search in Google Scholar PubMed PubMed Central

Kishi, T., Grass, L., Soosaipillai, A., Shimizu-Okabe, and Diamandis, E.P. (2003). Human kallikrein 8: immunoassay development and identification in tissue extracts and biological fluids. Clin. Chem.49, 87–96.10.1373/49.1.87Search in Google Scholar PubMed

Komatsu, N., Takata, M., Otsuki, N., Toyama, T., Ohka, R., Takehara, K., and Saijoh, K. (2003). Expression and localization of tissue kallikrein mRNAs in human epidermis and appendages. J. Invest. Dermatol.121, 542–549.10.1046/j.1523-1747.2003.12363.xSearch in Google Scholar

Komatsu, N., Saijoh, K., Toyama, T., OhKa, R., Otsuki, N., Hussack, G., Takehara, K., and Diamandis, E.P. (2005). Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases. Br. J. Dermatol.153, 274–281.10.1111/j.1365-2133.2005.06754.xSearch in Google Scholar

Laxmikanthan, G., Blaber, S.I., Bernett, M.J., Scarisbrick, I.A., Aparecida Juliano, M., and Blaber, M. (2005). 1.70 Å X-ray structure of human apo kallikrein 1: structural changes upon peptide inhibitor/substrate binding. Proteins58, 802–814.Search in Google Scholar

Little, S.P., Dixon, E.P., Norris, F., Buckley, W., Becker, G.W., Johnson, M., Dobbins, J.R., Wyrick, T., Miller, J.R., MacKellar, W., et al. (1997). Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzheimer's disease brain. J. Biol. Chem.272, 25135–25142.10.1074/jbc.272.40.25135Search in Google Scholar

Luo, L.Y., Katsaros, D., Scorilas, A., Fracchioli, S., Piccinno, R., Rigault de la Longrais, I.A., Howarth, D.J.C., and Diamandis, E.P. (2001). Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma. Clin. Cancer Res.7, 2372–2379.Search in Google Scholar

Luo, L.Y., Diamandis, E.P., Look, M.P., Soosaipillai, A.P., and Foekens, J.A. (2002). Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance. Br. J. Cancer86, 1790–1796.10.1038/sj.bjc.6600323Search in Google Scholar

Luo, L.Y., Yousef, G., and Diamandis, E.P. (2003). Human tissue kallikreins and testicular cancer. ARMIS111, 225–233.Search in Google Scholar

Magklara, A., Cheung, C.C., Asa, S.L., and Diamandis, E.P. (2000). Expression of prostate-specific antigen and human glandular kallikrein 2 in the thyroid gland. Clin. Chim. Acta300, 171–180.10.1016/S0009-8981(00)00319-3Search in Google Scholar

Margolius, H.S., Horwitz, D., Pisano, J.J., and Keiser, H.R. (1974). Urinary kallikrein excretion in hypertensive man. Relationships to sodium intake and sodium-retaining steroids. Circ. Res.35, 820–825.10.1161/01.RES.35.6.820Search in Google Scholar

Margolius, H.S. (1998). Kallikreins, kinins and cardiovascular diseases: a short review. Biol. Res.31, 135–141.Search in Google Scholar

McCormack, R.T., Rittenhouse, H.G., Finlay, J.A., Sokoloff, R.L., Wang, T.J., Wolfert, R.L., Lilja, H., and Oesterling, J. (1995). Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. Urology45, 729–744.10.1016/S0090-4295(99)80076-4Search in Google Scholar

Mitsui, S., Yamada, T., Okui, A., Kominami, K., Uemura, H., and Yamaguchi, N. (2000). A novel isoform of a kallikrein-like protease, TLSP/hippostatin (PRSS20), is expressed in the human brain and prostate. Biochem. Biophys. Res. Commun.272, 205–211.10.1006/bbrc.2000.2761Search in Google Scholar

Mitsui, S., Okui, A., Uemura, H., Mizuno, T., Yamada, T., Yamamura, Y., and Yamaguchi, N. (2002). Decreased cerebrospinal fluid levels of neurosin (KLK6), an aging-related protease, as a possible new risk factor for Alzheimer's disease. Ann. NY Acad. Sci.977, 216–223.10.1111/j.1749-6632.2002.tb04818.xSearch in Google Scholar

Naicker, T., Khedun, S.M., Moodley, D., and Bhoola, K. (1997). Localisation of tissue kallikrein in the kidney of black African women with early onset pre-eclampsia: a pilot study. Immunopharmacology36, 249–254.10.1016/S0162-3109(97)00028-3Search in Google Scholar

Naicker, S., Naidoo, S., Ramsaroop, R., Moodley, D., and Bhoola, K. (1999). Tissue kallikrein and kinins in renal disease. Immunopharmacology44, 183–192.10.1016/S0162-3109(99)00089-2Search in Google Scholar

Obiezu, C.V., Katsaros, D., Massobrio, M., Scorilas, A., Yousef, G.M., Fracchioli, S., Rigault de la Longrais, I.A., Arisio, R., and Diamandis, E.P. (2001). Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients. Clin. Cancer Res.7, 2380–2386.Search in Google Scholar

Obiezu, C.V., Soosaipillai, A., Jung, K., Stephan, C., Scorilas, A., Howarth, D.H., and Diamandis, E.P. (2002). Detection of human kallikrein 4 in healthy and cancerous prostatic tissues by immunofluorometry and immunohistochemistry. Clin. Chem.48, 1232–1240.10.1093/clinchem/48.8.1232Search in Google Scholar

Obiezu, C.V., Shan, S.J., Soosaipillai, A., Luo, L.Y., Grass, L., Sotiropoulou, G., Petraki, C.D., Papanastasiou, P.A., Levesque, M.A., and Diamandis, E.P. (2005). Human kallikrein 4: quantitative study in tissues and evidence for its secretion into biological fluids. Clin. Chem.51, 1432–1442.10.1373/clinchem.2005.049692Search in Google Scholar PubMed

ole-MoiYoi, O.K., Pinkus, G.S., Spragg, J., and Austen, K.F. (1979). Identification of human glandular kallikrein in the beta cell of the pancreas. N. Engl. J. Med.300, 1289–1294.10.1056/NEJM197906073002301Search in Google Scholar PubMed

Orstavik, T.B., Brandtzaeg, P., Nustad, K., and Pierce, J.V. (1980). Immunohistochemical localization of kallikrein in human pancreas and salivary glands. J. Histochem. Cytochem.28, 557–562.10.1177/28.6.6156199Search in Google Scholar PubMed

Orstavik, T.B., Brekke, I.B., Alumets, J., and Carretero, O.A. (1981). Kallikrein in rat pancreatic tissue after beta cell destruction or acinar cell atrophy. J. Histochem. Cytochem.29, 1431–1436.10.1177/29.12.6798105Search in Google Scholar PubMed

Petraki, C.D., Karavana, V.N., Skoufogiannis, P.T., Little, S.P., Howarth, D.J.C., Yousef, G.M., and Diamandis, E.P. (2001). The spectrum of human kallikrein 6 (zyme/protease M/neurosin) expression in human tissues, as assessed by immunohistochemistry. J. Histochem. Cytochem.49, 1431–1442.10.1177/002215540104901111Search in Google Scholar PubMed

Petraki, C.D., Karavana, V.N., Luo, L.Y., and Diamandis, E.P. (2002a). Human kallikrein 10 expression in normal tissues by immunohistochemistry. J. Histochem. Cytochem.50, 1247–1261.10.1177/002215540205000912Search in Google Scholar PubMed

Petraki, C.D., Karavana, V.N., Revelos. K.I., Luo. L.Y., and Diamandis, E.P. (2002b). Immunohistochemical localization of human kallikreins 6 and 10 in pancreatic islets. Histochem. J.34, 313–322.Search in Google Scholar

Petraki, C.D., Karavana, V.N., and Diamandis, E.P. (2003a). Human kallikrein 13 expression in normal tissues. An immunohistochemical study. J. Histochem. Cytochem.51, 493–501.10.1177/002215540305100411Search in Google Scholar PubMed

Petraki, C.D., Papanastassiou, P.A., Gregorakis, A.K., Karavana, V.N., Luo, L.Y., and Diamandis, E.P. (2003b). Immunohistochemical localization of human kallikreins 6, 10, and 13 in benign and malignant prostatic tissues. Prostate Cancer Prostatic Dis.6, 223–227.10.1038/sj.pcan.4500674Search in Google Scholar PubMed

Petraki, C.D., Gregorakis, A.K., Vaslamatzis, M.M., Papanastassiou, P., Yousef, G.M., and Diamandis, E.P. (2005). The immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma. Correlation with several prognostic factors. Tumor Biol.27, 1–7.Search in Google Scholar

Pinkus, G.S., Maier, M., Seldin, D.C., ole-MoiYoi, O.K., Austen, K.F., and Spragg, J. (1983). Immunohistochemical localization of glandular kallikrein in the endocrine and exocrine human pancreas. J. Histochem. Cytochem.31, 1279–1288.10.1177/31.11.6194204Search in Google Scholar

Pretlow, T.G., Pretlow, T.P., Yang, B., Kaetzel, C.S., Delmord, C.M., Kamis, S.M., Bodner, D.R., Kursh, E., Resnick, M.I., and Bradley, E.L. (1991). Tissue concentrations of prostate-specific antigen in prostatic carcinoma and benign prostatic hyperplasia. Int. J. Cancer49, 645–649.10.1002/ijc.2910490503Search in Google Scholar

Rae, F., Bulmer, B., Nicol, D., and Clements, J. (1999). The human tissue kallikreins (KLK13) and a novel KLK1 mRNA transcript are expressed in a renal cell carcinoma cDNA library. Immunopharmacology45, 83–88.10.1016/S0162-3109(99)00059-4Search in Google Scholar

Ramsaroop, R., Naicker, S., Naicker, T., Naidoo, S., and Bhoola, K.D. (1997). Tissue kallikrein and kinins in renal disease. Immunopharmacology36, 255–261.10.1016/S0162-3109(97)00030-1Search in Google Scholar

Rittenhouse, H.G., Finlay, J.A., Mikolajczyk, S.D., and Partin, A.W. (1998). Human kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate. Crit. Rev. Clin. Lab. Sci.35, 275–368.10.1080/10408369891234219Search in Google Scholar

Seidah, N.G. and Chretien, M. (1999). Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive peptides. Brain Res.848, 45–62.10.1016/S0006-8993(99)01909-5Search in Google Scholar

Shigemasa, K., Tian, X., Gu, L., Tanimoto, H., Underwood, L.J., O'Brien, T.J., and Ohama, K. (2004). Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favourable prognosis in ovarian cancer. Oncol. Rep.11, 1153–1159.Search in Google Scholar

Shimizu-Okabe, C., Yousef, G.M., Diamandis, E.P., Yoshida, S., Shiosaka, S., and Fahnestock, M. (2001). Expression of the kallikrein gene family in normal and Alzheimer's disease brain. Neuroreport12, 2747–2751.10.1097/00001756-200108280-00031Search in Google Scholar

Shvartsman, H.S., Lu, K.H., Lee, J., Lillie, J., Deavers, M.T., Clifford, S., Wolf, J.K., Mills, G.B., Bast, R.C., Gershenson, D.M., and Schmandt, R. (2003). Overexpression of kallikrein 10 in epithelial ovarian carcinomas. Gynecol. Oncol.90, 44–50.10.1016/S0090-8258(03)00257-9Search in Google Scholar

Siivola, P., Pettersson, K., Piironen, T., Lovgren, T., Lilja, H., and Bjartell, A. (2000). Time-resolved fluorescence imaging for specific and quantitative immunodetection of human kallikrein 2 and prostate-specific antigen in prostatic tissue sections. Urology56, 682–68810.1016/S0090-4295(00)00671-3Search in Google Scholar

Simmer, P.J. (2004). Kallikrein 4 is a secreted protein. Cancer Res.64, 8481–8483.10.1158/0008-5472.CAN-04-1660Search in Google Scholar PubMed

Stenman, U.-H. (1999). New ultrasensitive assays facilitate studies on the role of human glandular kallikrein (hK2) as a marker for prostatic disease. Clin. Chem.45, 753–754.10.1093/clinchem/45.6.753Search in Google Scholar

Stephan, C., Yousef, G.M., Scorilas, A., Jung, K., Jung, M., Kristiansen, G., Hauptmann, S., Bharaj, B.S., Nakamura, T., Loening, S.A., and Diamandis, E.P. (2003). Quantitative analysis of kallikrein 15 gene expression in prostate tissue. J. Urol.169, 361–364.10.1097/00005392-200301000-00107Search in Google Scholar

Tanimoto, H., Underwood, L.J., Shigemasa, K., Yan Yan, M.S., Clarke, J., Parmley, T.H., and O'Brien, T.J. (1999). The stratum corneum chymotryptic enzyme that mediates shedding and desquamation of skin cells is highly overexpressed in ovarian tumor cells. Cancer86, 2074–2782.10.1002/(SICI)1097-0142(19991115)86:10<2074::AID-CNCR27>3.0.CO;2-3Search in Google Scholar

Terashima, H., Atomi, Y., Kuroda, A., Morioka, Y., Ikekita, M., Aoki, K., Kamada, M., Kizuki, K., and Moriya, H. (1989). Purification of human pancreatic kallikrein and organ-specificities of human glandular kallikrein [in Japanese]. Nippon Shokakibyo Gakkai Zasshi86, 2556–2565.Search in Google Scholar

Terayama, R., Bando, Y., Takahashi, T., and Yoshida, S. (2004). Differential expression of neuropsin and protease M/neurosin in oligodendrocytes after injury to the spinal cord. Glia48, 91–101.10.1002/glia.20058Search in Google Scholar

Tremblay, R.R., Deperthes, D., Tetu, B., and Dube, J.Y. (1997). Immunohistochemical study suggesting a complementary role of kallikreins hK2 and hK3 (prostate-specific antigen) in the functional analysis of human prostate tumors. Am. J. Pathol.150, 455–459.Search in Google Scholar

Uehara, S., Honjyo, K., Furukawa, S., Hirayama, A., and Sakamoto, W. (1989). Role of the kallikrein-kinin system in human pancreatitis. Adv. Exp. Med. Biol.247B, 643–648.10.1007/978-1-4615-9546-5_106Search in Google Scholar

Underwood, L.J., Tanimoto, H., Wang, Y., Shigemasa, K., Parmley, K., and O'Brien, T.J. (1999). Cloning of tumor-associated differentially expressed gene-14, a novel serine protease overexpressed by ovarian carcinoma. Cancer Res.59, 4435–4439.Search in Google Scholar

Vio, C.P., Roa, J.P., Silva, R., and Powers, C.A. (1990). Localization of immunoreactive glandular kallikrein in lactotrophs of the rat anterior pituitary. Neuroendocrinology51, 10–14.10.1159/000125309Search in Google Scholar

Williams, R.J., Henderson, L.M., Naidoo, Y., Cassim, B., Elson, C.J., and Bhoola, K.D. (1997). Immunocytochemical analysis of tissue kallikrein and the kinin moiety in rheumatoid synovial fluid neutrophils. Br. J. Rheumatol.36, 420–425.10.1093/rheumatology/36.4.420Search in Google Scholar

Wolf, W.C., Harley, R.A., Sluce, D., Chao, L., and Chao, J. (1999). Localization and expression of tissue kallikrein and kallistatin in human blood vessels. J. Histochem. Cytochem.47, 221–228.10.1177/002215549904700210Search in Google Scholar

Xi, Z., Klokk, T.I., Korkmaz, K., Kurys, P., Elbi, C., Risberg, B., Danielsen, H., Loda, M., and Saatcioglu, F. (2004). Kallikrein 4 is a predominantly nuclear protein and is overexpressed in prostate cancer. Cancer Res.64, 2365–2370.10.1158/0008-5472.CAN-03-2025Search in Google Scholar

Yamanaka, H., He, X., Matsumoto, K., Shiosaka, S., and Yoshida, S. (1999). Protease M/neurosin mRNA is expressed in mature oligodendrocytes. Brain Res. Mol. Brain Res.71, 217–224.10.1016/S0169-328X(99)00187-4Search in Google Scholar

Yayama, K., Kunimatsu, N., Teranishi, Y., Takano, M., and Okamoto, H. (2003). Tissue kallikrein is synthesized and secreted by human vascular endothelial cells. Biochem. Biophys. Acta1593, 231–238.10.1016/S0167-4889(02)00393-2Search in Google Scholar

Yoi, O.O., Seldin, D.C., Spragg, J., Pinkus, G.S., and Austen, K.F. (1979). Sequential cleavage of proinsulin by human pancreatic kallikrein and a human pancreatic kininase. Proc. Natl. Acad. Sci. USA76, 3612–3616.Search in Google Scholar

Yousef, G.M. and Diamandis, E.P. (2001). The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr. Rev.22, 184–204.Search in Google Scholar

Yousef, G.M. and Diamandis, E.P. (2002). Human tissue kallikreins: a new enzymatic cascade pathway? Biol. Chem.383, 1045–1057.10.1515/BC.2002.113Search in Google Scholar

Yousef, G.M., Scorilas, A., Magklara, A., Soosaipillai, A., and Diamandis, E.P. (2000). The KLK7 (PRSS6) gene, encoding for the stratum corneum chymotryptic enzyme is a new member of the human kallikrein gene family – genomic characterization, mapping, tissue expression and hormonal regulation. Gene254, 119–128.10.1016/S0378-1119(00)00280-8Search in Google Scholar

Yousef, G.M., Magklara, A., Chang, A., Jung, K., Katsaros, D., and Diamandis, E.P. (2001). Cloning of a new member of the human kallikrein gene family, KLK14, which is down-regulated in different malignancies. Cancer Res.61, 3425–3431.Search in Google Scholar

Yousef, G.M., Borgono, C.A., Scorilas, A., Ponzone, R., Biglia, N., Iskander, L., Polymeris, M.E., Roagna, R., Sismondi, P., and Diamandis, E.P. (2002a). Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis. Br. J. Cancer87, 1287–1293.10.1038/sj.bjc.6600623Search in Google Scholar

Yousef, G.M., Obiezu, C.V., Jung, K., Stephan, C., Scorilas, A., and Diamandis, E.P. (2002b). Differential expression of kallikrein gene 5 in cancerous and normal testicular tissues. Urology60, 714–718.10.1016/S0090-4295(02)01811-3Search in Google Scholar

Yousef, G.M., Scorilas, A., Chang, A., Rendl, L., Diamandis, M., Jung, K., and Diamandis, E.P. (2002c). Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues. Prostate51, 126–132.10.1002/pros.10067Search in Google Scholar

Yousef, G.M., Scorilas, A., Kyriakopoulou, L.G., Rendl, L., Diamandis, M., Ponzone, R., Biglia, N., Gial, M., Roagna, R., Sismondi, P., and Diamandis, E.P. (2002d). Human kallikrein gene 5 (KLK5) expression by quantitative PCR: an independent indicator of poor prognosis in breast cancer. Clin. Chem.48, 1241–1250.10.1093/clinchem/48.8.1241Search in Google Scholar

Yousef, G.M., Scorilas, A., Magklara, A., Memari, N., Ponzone, R., Sismondi, P., Biglia, N., Abd Ellatif, M., and Diamandis, E.P. (2002e). The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer. Br. J. Cancer87, 1294–1300.10.1038/sj.bjc.6600590Search in Google Scholar

Yousef, G.M., Kishi, T., and Diamandis, E.P. (2003a). Role of kallikrein enzymes in the central nervous system. Clin. Chim. Acta329, 1–8.10.1016/S0009-8981(03)00004-4Search in Google Scholar

Yousef, G.M., Polymeris, M., Yacoub, G.M., Scorilas, A., Soosaipaillai, A., Popalis, C., Fracchioli, S., Katsaros, D., and Diamandis, E.P. (2003b). Parallel overexpression of seven kallikrein genes in ovarian cancer. Cancer Res.63, 2223–2227.Search in Google Scholar

Yousef, G.M., Scorilas, A., Katsaros, D., Fracchioli, S., Iskander, L., Borgono, C., Rigault de la Longrais, I.A., Puopolo, M., Massobrio, M., and Diamandis, E.P. (2003c). Prognostic value of the human kallikrein gene 15 expression in ovarian cancer. J. Clin. Oncol.21, 3119–3126.10.1200/JCO.2003.09.111Search in Google Scholar PubMed

Yousef, G.M., Scorilas, A., Nakamura, T., Ellatif, M.A., Ponzone, R., Biglia, N., Maggiorotto, F., Roagna, R., Sismondi, P., and Diamandis, E.P. (2003d). The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer. Breast Cancer Res. Treat.78, 149–158.10.1023/A:1022931403825Search in Google Scholar

Yousef, G.M., Obiezu, C.V., Luo, L.Y., Magklara, A., Borgono, C.A., Kishi, T., Memari, N., Michael, P., Sidiropoulos, M., Kurlender, L., et al. (2005). Human tissue kallikreins: from gene structure to function and clinical applications. Adv. Clin. Chem.39, 11–79.10.1016/S0065-2423(04)39002-5Search in Google Scholar

Published Online: 2006-06-26
Published in Print: 2006-06-01

©2006 by Walter de Gruyter Berlin New York

Downloaded on 27.4.2024 from https://www.degruyter.com/document/doi/10.1515/BC.2006.084/html
Scroll to top button